DZ
DefZone.Net

Kien thuc cong nghe & giai tri

Wiki Article

Draft:Sylvie Trottier

Nguồn dữ liệu từ Wikipedia, hiển thị bởi DefZone.Net

Xem trên WikipediaBài ngẫu nhiên khác
  • Comment: If she holds a university appointment, please include it together with her academic rank and a reference for the information. Eastmain (talk • contribs) 22:47, 19 January 2026 (UTC)
  • Comment: Please don't add sources written by the subject except where required for verification. WP:REFSPAM will not help your article get accepted. Somepinkdude (talk) 01:34, 23 December 2025 (UTC)
Sylvie Trottier
Born (1952-05-20) May 20, 1952 (age 73)
Quebec City, Canada
Alma materLaval University (BSc & MSc)

McGill University (MDCM)

University of Göteborg (Fellow, Infectious Diseases)
Known forClinical research in infectious diseases, HIV/AIDS and comorbidities, HPV, vaccines, Infection prevention and control in healthcare settings.
Scientific career
FieldsInfectious Diseases
InstitutionsLaval University

CHU de Quebec Research Center

Quebec Heart and Lung Institute

Sylvie Trottier is a Canadian physician and a medical researcher in the field of infectious diseases, with a focus on HIV/AIDS. She is known for her clinical work and participation in multicentre clinical trials on viral infections and other infectious diseases.

Education

[edit]

Trottier obtained two undergraduate degrees from Laval University: a Bachelor of Science in Microbiology in 1975 and a Bachelor of Science in Biochemistry in 1976. She completed a Master's degree in Medical Microbiology in 1978 under the supervision of Michel G. Bergeron.

She earned her medical degree (MDCM) from McGill University in 1982 and subsequently returned to Laval University for a residency in infectious diseases, completed in 1985.

In 1985, Trottier undertook postdoctoral training at the University of Göteborg in Sweden, where she worked with Catharina Svanborg-Edén on mucosal immunity and bacterial pathogenesis. In this context, she co‑authored a study on germ transmission in daycare settings, describing colonization dynamics of nontypeable Haemophilus influenzae in healthy children.

Career

[edit]

Trottier joined the Québec Heart and Lung Institute (IUCPQ) and the CHU de Québec – Université Laval (CHUL) in 1986, at the beginning of the HIV/AIDS pandemic in Quebec. She became involved in the care of people living with HIV and in clinical research related to HIV and other infectious diseases within these institutions.

In 1995, she was appointed Chief of Clinical Research at the Infectious Disease Research Centre (Centre de recherche en infectiologie, CRI) of Laval University. The same year, she became director of the "Unité hospitalière de recherche, d'enseignement et de soins sur le sida" (UHRESS) at CHUL, a multidisciplinary HIV/AIDS unit providing specialized care, research and teaching for patients from Eastern Quebec.[1] From 1999 to 2015, she served as Director of the Clinical Laboratories at IUCPQ. She was Director of the Department of "Microbiologie‑Infectiologie et Immunologie" in the Faculty of Medicine at Laval University from 2011 to 2019.

Research

[edit]

Trottier has participated as a clinical investigator in national and international clinical trials in HIV, influenza, herpesvirus infections, Clostridioides difficile infection and other communicable diseases.[2][3] Her co‑authored work includes randomized trials on influenza antivirals, herpes antivirals and HIV antiretroviral strategies, as well as studies on C. difficile diagnosis and infection control. She contributed to large international HIV studies such as the SMART trial on antiretroviral therapy strategies.[4]

From 2009 to 2015, Dr. Sylvie Trottier contributed to national influenza vaccine research through the PHAC/CIHR Influenza Research Network (PCIRN), serving as an investigator in the Serious Outcomes Surveillance (SOS) Network, which conducted hospital-based surveillance and vaccine effectiveness studies across Canada.[5]

In 2016, she participated in the first clinical study of a Zika virus vaccine in Canada, leading the extensive clinical trial at the Université Laval site in Quebec City under Professor Gary Kobinger's guidance.[6][7]

During the COVID‑19 pandemic, Trottier and collaborators examined SARS‑CoV‑2 infection and immune response in at‑risk essential workers in Quebec, including retail workers.[8] Their work addressed infection rates and risk factors at the onset of the pandemic.[9]

According to Google Scholar, her publications have received more than 9,000 citations, with several hundred citations per year in recent years.[10] Her cited work covers HIV, respiratory viruses, bacterial infections and vaccine or antiviral evaluations.

Awards and honors

[edit]
  • 2008 - Farha Foundation Award « Hommage aux Héros » in recognition of 20 years of fighting HIV/AIDS and caring for patients.[11]
  • 2018 - Isabel and Michèle Beauchemin-Perreault Prize — Excellence Award from the Health and Social Services Network in the "Safety of Care and Services" category awarded to the IUCPQ infection prevention team.[12]
  • 2019 - Laureate of the Council of physicians, dentists and pharmacists (CMDP of IUCPQ) category « Qualité de l'acte » (Best in Patients' Safety).[13]
  • 2023 - CHU de Quebec Research Center Awards "Prix Découverte" - Best Collaborative Group.[14]
  • 2025 - CHU de Québec Research Center Awards "Prix Recherche-Carrière".[15][16]

References

[edit]
  1. ^ Média, Boréale. "UHRESS - Centre de recherche en infectiologie". Centre de recherche en infectiologie (in French). Archived from the original on 2025-12-19. Retrieved 2026-01-12.
  2. ^ "Recherche clinique en infectiologie : une équipe hyperactive pour des avancées significatives | CHU de Québec-Université Laval". www.chudequebec.ca (in French). Retrieved 2026-01-12.
  3. ^ "Sylvie Trottier". The CTN+. Retrieved 2026-01-12.
  4. ^ "SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350". aidsmap.com. 2008-04-14. Retrieved 2026-01-12.
  5. ^ "Annual Reports - CIRN". CIRN - Canadian Immunization Research Network. See "PCIRN-Annual-ReportFINAL-2013.pdf". 2014-06-02. Retrieved 2026-01-12.{{cite web}}: CS1 maint: others (link)
  6. ^ "First international clinical study on Zika virus vaccine set for Quebec City | Globalnews.ca". Global News. Retrieved 2026-01-12.
  7. ^ "Canada home to the first clinical study for a Zika vaccine | About us | Université Laval". www.ulaval.ca. Retrieved 2026-01-12.
  8. ^ Featured, Science (2025-03-27). "What Put Retail Workers at Risk for COVID Might Surprize You | Science Featured Series". Retrieved 2026-01-12.
  9. ^ ICI.Radio-Canada.ca, Zone Santé- (2021-06-14). "Étude sur la COVID-19 chez les travailleurs du secteur du détail". Radio-Canada (in Canadian French). Retrieved 2025-04-14.
  10. ^ "Sylvie Trottier". scholar.google.com. Retrieved 2025-11-22.
  11. ^ "The Farha Foundation's seventh annual HEROES NIGHT | Positively Positive". www.positivelypositive.ca. Retrieved 2025-04-14.
  12. ^ https://epe.lac-bac.gc.ca/100/201/300/institut_iucpq/2018/29no2.pdf?nodisclaimer=1
  13. ^ https://epe.lac-bac.gc.ca/100/201/300/institut_iucpq/2019/vol30_no2.pdf?nodisclaimer=1
  14. ^ Média, Boréale; cri-laval (2022-05-26). "First edition of the Centre de recherche du CHU de Québec - Université Laval "Prix Découverte" Awards - Two wins for IDRC researchers". Centre de recherche en infectiologie. Retrieved 2025-04-14.
  15. ^ "Prix Recherche | CHU de Québec-Université Laval". www.chudequebec.ca (in French). Retrieved 2025-11-22.
  16. ^ "Prix Diamants – Dre Sylvie Trottier et Aurélie de Rus Jacquet mises à l'honneur". www.chudequebec.ca. Retrieved 2026-01-12.

See also

[edit]